Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Diamyd Medical Aktiebolag
AB
Active
Org 5562423797
Kungsgatan 29, 111 56
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 1984
20-49 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Diamyd Medical Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
AE
Anders Essen-Möller
Chief Executive Officer
Chief Executive Officer
2026
UH
Ulf Henrik Hannelius
Chief Executive Officer
Chief Executive Officer
2022
SJ
Sten Johan Pharmanson
Chief Auditor
Chief Auditor
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
MA
Mark Alvin Atkinson
Board of Directors
2022
MT
Maria T B Marklund Essen-Möller
Board of Directors
2022
KM
Karin Margareta Hehenberger
Board of Directors
2022
EK
Erik Kjellsson Nerpin
Chairman
2022
KE
Karin Elisabeth Rosén
Board of Directors
2024
CT
Carl Torbjörn Bäckström
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Diamyd Medical Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network